Evolent Health Inc

EVH

Add to Watchlist

3.960USD

-0.140-3.41%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

Evolent Health Inc's Score

Industry at a Glance

Industry Ranking

48 / 206

Overall Ranking

131 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Evolent Health Inc Highlights

StrengthsRisks

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 1.88B.

Overvalued

The company’s latest PE is -0.85, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 123.18M shares, decreasing 28.70% quarter-over-quarter.

Held by Paul Tudor Jones

Star Investor Paul Tudor Jones holds 702.12K shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

6.464

Target Price

+57.66%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Evolent Health Inc is 6.38, ranking 151 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 496.25M, representing a year-over-year increase of 2.60%, while its net profit experienced a year-over-year increase of 63.14%.

Score

Industry at a Glance

Previous score

6.38

Change

0



Financials

4.90

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.28

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.42

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.18

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.14

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Evolent Health Inc is 8.39, ranking 22 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.85, which is -49.40% below the recent high of -0.43 and -20606.90% above the recent low of -175.04.

Score

Industry at a Glance

Previous score

8.39

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 48/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Evolent Health Inc is 8.38, ranking 46 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 9.75, with a high of 16.00 and a low of 6.00.

Score

Industry at a Glance

Previous score

8.38

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Evolent Health Inc is 7.18, ranking 60 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.73 and the support level at 3.00, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.52

Change

-1.34

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Evolent Health Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 109.51%, representing a quarter-over-quarter decrease of 19.86%. The largest institutional shareholder is Lee Ainslie, holding a total of 2.54M shares, representing 2.26% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Cadian Capital Management LP

11.09M

-5.49%

BlackRock Institutional Trust Company, N.A.

8.21M

+4.53%

UBS Financial Services, Inc.

6.11M

+79.57%

Morgan Stanley & Co. LLC

7.49M

-0.01%

Rubicon Founders, LLC

5.82M

--

Engaged Capital, LLC

5.56M

-1.77%

D. E. Shaw & Co., L.P.

5.27M

+92.47%

State Street Investment Management (US)

2.94M

-1.10%

Geode Capital Management, L.L.C.

2.73M

-0.86%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Evolent Health Inc is 4.30, ranking 106 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.85. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Evolent Health Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Evolent Health Inc

EVH

7.40 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.68 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.58 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment